The developers behind the well-regarded SkinVision app have launched the technology in New Zealand, providing Kiwis with a quick and easy way to monitor and track the shape and appearance of moles in case of melanoma.

Aimed at people with a predisposition toward skin cancer, the app is scientifically proven and is backed by Europe's CE certification authority. First developed in Romania, the company is now based in the Netherlands and is currently awaiting FDA certification in the US.